Basic aspects of the management of the diabetic patient and COVID-19

Welcome to the Online Course Basics of Diabetic Patient Management and COVID-19!

The high association of T2DM with COVID-19 infection and its complications has been seen from many points of view. This association is based on multiple factors that go through the high association that DM presents with other risk factors for infection such as hypertension and obesity, in addition to the consequent cardiovascular diseases.

The alteration of the innate immunity that diabetics present confers a higher risk of infection. The relationship with the angiotensin II receptor, which uses cells from different tissues as a gateway, making this infection a pathology that is not exclusively limited to the airways. The pancreatic involvement is notable due to direct cytoxicity of the ß cell, its ability to aggravate the low-grade infection already present in diabetics, in addition to triggering a release of cytokines: high amounts of IL-6, IL-1ß, necrosis factor tumor to (TNFa), monocyte chemoattractant protein-1 (MCP-1), with an uncontrolled hyperinflammatory systemic response. It should be noted that in the diabetic patient another risk factor is added, because in the midst of an underlying hypercoagulant / pro-thrombotic state predisposed by the mere presence of DM2, there is an over-activation of the coagulation cascade in COVID-19 that can lead to fatal thromboembolic complications and increased mortality as seen.

Course objectives:
To answer many of the questions that have been raised and are raised in diabetic patients with COVID-19 infection. The course starts from a pathophysiological analysis that helps to understand the greater morbidity and mortality of diabetic patients, to make way for seven modules in video format that explain the most important aspects of the affection of the diabetic patient.

* In the Preview tab, you will find a video explaining the registration process for the course and the presentation by Dr. Pablo Miramontes.